Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Syncona (SYNC)

Price 126.00p on 24-04-2024 at 16:56:26
Change 2.00p 1.61%
Buy 125.20p
Sell 125.00p
Buy / Sell SYNC Shares
Last Trade: Unknown 805.00 at 126.00p
Day's Volume: 1,152,173
Last Close: 126.00p
Open: 126.00p
ISIN: GG00B8P59C08
Day's Range 124.00p - 127.00p
52wk Range: 105.00p - 162.20p
Market Capitalisation: £823m
VWAP: 124.88753p
Shares in Issue: 653m

Recent Trades History Syncona (SYNC)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 805 126.00p OTC Trade
16:56:17 - 24-Apr-24
Unknown* 2,309 126.00p OTC Trade
16:13:42 - 24-Apr-24
Buy* 17,097 126.00p Ordinary
15:35:58 - 24-Apr-24
Buy* 1,838 126.00p Automatic Execution
15:35:44 - 24-Apr-24
Buy* 88,237 126.00p Suspected BUY Trade
15:35:10 - 24-Apr-24
Buy* 1 125.20p Automatic Execution
15:27:12 - 24-Apr-24
Buy* 46 125.20p Automatic Execution
15:27:11 - 24-Apr-24
Buy* 23 125.20p Automatic Execution
15:27:09 - 24-Apr-24
Buy* 46 125.20p Automatic Execution
15:25:32 - 24-Apr-24
Buy* 23 125.20p Automatic Execution
15:25:31 - 24-Apr-24

Share Price History for Syncona

Time period:
to
Date Open High Low Close Volume

Share News for Syncona

Syncona agrees to sell stake in investee company for GBP7.4 million

11th Apr 2024 14:22

(Alliance News) - Syncona Ltd on Thursday said it has reached an agreement to sell one of its portfolio companies to US biotechnology firm, Century Therapeutics Inc. Read More

IN BRIEF: Syncona notes investee Achilles's annual loss narrows

4th Apr 2024 17:06

Syncona Ltd - London-based investor in healthcare companies - Notes that the loss of investee and clinical-stage biopharmaceutical company Achilles Therapeutics PLC narrows by 2.7% to USD68.2 million in 2023 from USD71.1 million in 2022. General and administrative costs contract by 19% to USD17.0 million from USD21.1 million. According to Syncona's website, the company has a 25% stake in Achilles. Read More

Syncona portfolio company Autolus posts widened loss for 2023

14th Mar 2024 14:16

(Alliance News) - Syncona Ltd on Thursday noted the 2023 results of one of its life science portfolio companies, which showed a widened loss and an increase in annual expenses. Read More

IN BRIEF: Freeline shareholders approve Syncona acquisition

12th Feb 2024 18:01

Syncona Ltd - London-based investor in healthcare companies - Freeline Therapeutics Holdings PLC shareholders approve acquisition by Syncona. Read More

UPDATE: Syncona portfolio strengthens thanks to Autolus

8th Feb 2024 13:45

(Alliance News) - Syncona Ltd on Thursday said its portfolio company Autolus Therapeutics PLC has struck a deal to work with BioNTech to commercialise its CAR-T programmes. Read More

FTSE 100 Latest
Value8,040.38
Change-4.43

Login to your account

Forgot Password?

Not Registered